In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 27083271.
- Also identified by DOI 10.1016/j.kint.2016.03.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hyperparathyroidism plays a central role in the disordered bone mineral metabolism of chronic kidney disease, and has been associated with increased cardiovascular morbidity and mortality in that setting. A recent study suggests a novel role for parathyroid hormone and its receptor in muscle wasting and cachexia occurring in advanced chronic kidney disease.
Medical subject headings
- Cachexia
- Parathyroid Hormone